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Abstract
Background: Gestational diabetes related morbidity increases along the continuum of the glycemic spectrum.
Perinatal mortality, as a complication of gestational diabetes, has been little investigated. In early studies, an
association was found, but in more recent ones it has not been confirmed. The Brazilian Study of Gestational
Diabetes, a cohort of untreated pregnant women enrolled in the early 1990’s, offers a unique opportunity to
investigate this question. Thus, our objective is to evaluate whether perinatal mortality increases in a continuum
across the maternal glycemic spectrum.
Methods: We prospectively enrolled and followed 4401 pregnant women attending general prenatal care clinics in
six Brazilian state capitals, without history of diabetes outside of pregnancy, through to birth, and their offspring
through the early neonatal period. Women answered a structured questionnaire and underwent a standardized 2-
hour 75-g oral glucose tolerance test (OGTT). Obstetric care was maintained according to local protocols. We
obtained antenatal, delivery and neonatal data from hospital records. Odds ratios (OR) were estimated using
logistic regression.
Results: We ascertained 97 perinatal deaths (67 fetal and 31 early neonatal). Odds of dying increased according to
glucose levels, statistically significantly so only for women delivering at gestational age ≥34 weeks (p < 0.05 for
glycemia-gestational age interaction). ORs for a 1 standard deviation difference in glucose, when analyzed
continuously, were for fasting 1.47 (95% CI 1.12, 1.92); 1-h 1.55 (95% CI 1.15, 2.07); and 2-h 1.53 (95% CI 1.15, 2.02).
The adjusted OR for IADPSG criteria gestational diabetes was 2.21 (95% CI 1.15, 4.27); and for WHO criteria
gestational diabetes, 3.10 (95% CI 1.39, 6.88).
Conclusions: In settings of limited detection and treatment of gestational diabetes mellitus, women across a
spectrum of lesser than diabetes hyperglycemia, experienced a continuous rise in perinatal death with increasing
levels of glycemia after 34 weeks of pregnancy. Current GDM diagnostic criteria identified this increased risk of
mortality.
Background
Gestational diabetes is generally defined as a state of
glucose intolerance detected during pregnancy, but the
level of hyperglycemia used in its definition varies
remarkably around the world, as does its prevalence [1].
Gestational diabetes is an established risk factor for
adverse maternal outcomes such preeclampsia and
future type 2 diabetes, as well as neonatal outcomes
such as macrosomia, hypoglycemia and birth injuries
[2-6].
Perinatal mortality was reported to be higher among
women with gestational diabetes in some initial studies
[7,8]. However, the HAPO Study, a large multi-country
cohort study conducted between 2000 and 2006, found
no association between glucose levels and perinatal mor-
tality [6]. In fact, this association was also not found in
an additional large, retrospective cohort study conducted
in a developing country [9].
Worldwide, an estimated 6.3 million perinatal deaths,
of which 57% are fetal deaths, occur annually [10]. The
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ity is controversial, particularly with respect to milder
degrees of hyperglycemia [6-9]. We have previously
reported greater perinatal death for women meeting
American Diabetes Association criteria for gestational
diabetes in the Brazilian Study of Gestational Diabetes
(Estudo Brasileiro de Diabetes Gestacional; EBDG) [3].
This large cohort study was conducted in the early
1990’s, a time during which the screening and treatment
for gestational diabetes was controversial and not wide-
spread in Brazil.
The aim of this report is to describe, in the EBDG
population, the association of perinatal death with
maternal glucose levels when examined across the conti-
nuum of glucose levels and additionally using current
diagnostic criteria.
Methods
The Brazilian Study of Gestational Diabetes investigated
a cohort of Brazilian pregnant women enrolled between
1991 and 1995, allowing analysis of untreated women
with hyperglycemia below that diagnostic of diabetes
outside of pregnancy [3]. We consecutively recruited
5564 women aged 20 or more years, with no history of
diabetes outside pregnancy, who attended general prena-
tal care clinics in six Brazilian state capitals (Porto Ale-
gre, São Paulo, Rio de Janeiro, Salvador, Fortaleza and
Manaus). Of these, 4998 underwent a 2-hour 75-g
OGTT between their 24th and 28th weeks of pregnancy
following standard procedures previously described [3].
After excluding 21 women meeting diagnostic criteria
for diabetes outside of pregnancy, 2 with gestational dia-
betes treated with insulin, 49 twin pregnancies, one with
questionable birth weight and 524 with birth less than
28 weeks of pregnancy, we examined 4401 pregnancies.
The study protocol was approved by each local institu-
tional ethics committee, and women consented to parti-
cipate after being informed about the nature of the
study.
All women answered a structured questionnaire at
enrollment and were followed through delivery and in
the postpartum period through chart review. We calcu-
lated pre-pregnancy BMI using self-reported weight and
measured height. All patients received routine obstetric
care by their physicians. We obtained neonatal data
from hospital records. We defined perinatal death as a
death of offspring occurring after 28 weeks of pregnancy
or up to seven complete days of life [10], and macroso-
mia as a birthweight at or above the gestational age-spe-
cific (by week) 90th percentile of the study sample, as
previously described [3].
For descriptive analyses, we used glucose categories
previously defined to permit comparison with previous
studies [6]. The Cochrane-Armitage test was used to
evaluate statistical significance of trends [11]. We
employed analysis of covariance to compare adjusted
means of glycemia between groups. We used logistic
regression to estimate odds ratios for perinatal death
associated with a 1 standard deviation difference in fast-
ing, 1-hour and 2-hour plasma glucose levels adjusted
for covariates. Selection of variables for inclusion in
regression models was based on their relationship with
outcomes. Due to the small number of events, final
models included only variables which led to the largest
change in the odds ratio Similar regression analyses
were done having the categorical variable gestational
diabetes as the main exposure. Two definitions were
used, that of the World Health Organization (WHO)
[12] and that of the International Association of Dia-
betes and Pregnancy Study Groups (IADSPG) [13]. A
significant difference was defined as a p value < 0.05.
Results
Clinical characteristics of the study sample, including
plasma glucose means for fasting, 1-hour and 2-hour
moments of the 75 g OGTT are given in Table 1.
We ascertained 97 perinatal deaths, 66 being fetal and
31 occurring in the early neonatal period. The perinatal
mortality rate estimated from week 28 of pregnancy to 1
week postpartum was 22.0/1000. A total of 38 (39%)
deaths occurred before week 34 of pregnancy and 59
(61%), thereafter. Macrosomia was observed in 3 (7.5%)
perinatal deaths and in 376 (9.7%) of those surviving the
perinatal period (p = 0.21); small for gestational age in
16 (39.0%) deaths and 368 (9.9) survivors (p < 0.001).
On average, mothers of offspring with perinatal death
had one year less education (6.9 vs. 7.8; p = 0.02) than
those with surviving offspring, but similar mean age
(28.3 vs. 27.8 years; p = 0.38), pre-pregnancy BMI (23.2
Table 1 Demographic and clinical characteristics of study
subjects.
Mean SD Minimum Maximum
Age (years) 27.8 5.5 20.0 48.0
Pre-pregnancy body mass index
(kg/m
2)
23.4 4.1 12.9 52.9
Education (years) 7.8 3.7 0 16.0
Birth weight (g) 3207.0 558.2 650.0 5650.0
Gestational age at delivery
(weeks)
38.9 2.2 28.0 44.8
Plasma glucose (mg/dl)
Fasting 81.7 10.6 43.0 124.0
1-hour 121.7 27.9 41.0 245.0
2-hour 103.7 22.7 33.0 199.0
Gestational age at delivery
(weeks)
38.9 2.2 28.0 44.8
Birth weight (g) 3207.0 558.2 650 5650
SD = standard deviation
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Page 2 of 6vs. 23.4; p = 0.61), skin color (white 36.1% vs. 44.7%; p =
0.09), parity (nulliparity 24.1% vs. 30.8%; p = 0.2) and
rates of cesarean section (40.4% vs. 37.8%; p = 0.6).
Over the gestational age span evaluated, fasting (83.2
mg/d vs. 81.5 mg/dl; p = 0.17) and 1-hour (124.8 mg/dl
vs. 118.9mg/dl; p = 0.07) glucose values, adjusted for
maternal age, skin color, years of education, parity and
pre-pregnancy body mass index, did not differ for those
with and without perinatal death. However, the adjusted
mean 2-hour glucose level was higher in women suffer-
ing perinatal death (110.2 mg/dl vs. 104.2 mg/dl; p =
0.03).
Similarly, greater odds of perinatal death, adjusted
through logistic regression for race, parity, maternal age,
pre-pregnancy BMI and years of education, were found
only for higher glucose levels at 2-h post load: OR 1.28;
95% CI 1.02, 1.59) for a 1 standard deviation difference
in glucose level (Table 2). The association between glu-
cose and perinatal death varied depending upon the
gestational period in which it was evaluated (p < 0.05
for the glycemia-gestational age interaction for all 3 glu-
cose tolerance moments). For events occurring at 34
weeks or later, a one standard deviation increase in glu-
cose was associated with greater odds of dying (Table
2): fasting 1.47 (95% CI 1.12, 1.92); 1-h 1.55 (95% CI
1.15, 2.07) and 2-h 1.53 (95% CI 1.15, 2.02).
To evaluate to what extent this association occurs
across the continuum of glucose levels, we plotted the
crude incidence of perinatal death according to glucose
categories (Figure 1). As seen in the upper panel (gesta-
tional age at delivery ≥ 28 weeks), incidence of perinatal
death increased according to glucose categories, but lin-
ear trend was not statistically significant. For women
with delivery at gestational age ≥ 34 weeks (lower
panel), the incidence of perinatal death increased with
increasing glucose values at all moments of the OGTT:
from 1.4% to 2.6% comparing the lowest (<75 mg/dl) to
the highest (≥95 mg/dl) fasting glucose; from 0.9% to
3.1% comparing the lowest (≤105 mg/dl) to highest 1-
hour glucose (≥194 mg/dl) and from 0.7% to 4.5% com-
paring the lowest (≤90 mg/dl) to highest 2-hour glucose
(≥158 mg/dl). Linear trends were statistically significant
for the 1-hour glucose (p = 0.01) and the 2-hour (p <
0.001) glucose categories. Additionally, when consider-
ing only this latter period, mean plasma glucose values
(mg/dl), adjusted for maternal age, skin color, years of
education, parity and pre-pregnancy body mass index,
were higher in women with a perinatal death for all glu-
cose measurements: fasting (85.8 mg/dl vs. 81.5 mg/dl p
< 0.05), 1-hour (129.9 mg/dl vs. 118.8 mg/dl; p < 0.01)
and 2-hour (114.2 mg/dl vs. 104.4 mg/dl; p < 0.01).
Logistic regression analysis, evaluating the association
of perinatal mortality with the IADPSG and the WHO
criteria for gestational diabetes, also demonstrated asso-
ciations only for women delivering after 34 weeks
(Table 3). Associations were always somewhat larger
with the WHO criteria (adjusted OR 3.10 (95% CI 1.39,
6.88), than with the IADPSG criteria (adjusted OR 2.21
(95% CI 1.15, 4.27).
Discussion
Perinatal mortality is the most serious adverse outcome
of pregnancy, but evidence for its association with lesser
than diabetes hyperglycemia is less clear. We report
excess perinatal mortality risk with increasing glucose
values across the spectrum of lesser than diabetes hyper-
glycemia in late pregnancy in a cohort study conducted
at a setting of limited testing for and treatment of gesta-
tional diabetes. This greater risk of death was present in
w o m e nw i t hG D Md i a g n o s e db yb o t ht h eW H Oa n d
the IADPGS criteria.
The literature is controversial on this issue. Like ours,
some previous studies have shown that glycemic levels
are associated with perinatal mortality. O’Sullivan et al.
[8] found a 4-fold increase in perinatal mortality rate in
women with untreated gestational diabetes. Pettit et al.
[7] reported a direct association between glucose levels
from a 75-g 2-hour glucose challenge and perinatal
mortality in Pima Indians. However, both of these stu-
dies included women with more severe hyperglycemia.
A more recent major study, HAPO, did not find an
association in unadjusted logistic analysis [6]. Several
differences between the HAPO study design and ours
could explain this difference. First, obstetric care has
improved dramatically around the world. This has led
to major decreases in perinatal mortality from the
early 1990s, when EBDG was performed, to the early
years of the current decade, when HAPO was
Table 2 Association of perinatal mortality* with levels of
fasting, and 1-hour and 2-hour glucose post 75 g load
for women delivering at different gestational periods
Fasting 1-hour 2-hour
OR 95% CI OR 95% CI OR 95% CI
Total sample
Model 1 1.11 0.91,1.35 1.13 0.93,1.38 1.14 0.93,1.38
Model 2 1.16 0.93,1.45 1.25 0.99,1.57 1.28 1.02,1.59
Delivery between 28
and 33 weeks
Model 1 0.93 0.64,1.34 0.87 0.59,1.27 0.82 0.56,1.21
Model 2 0.83 0.54,1.29 0.85 0.54,1.34 0.97 0.62,1.52
Delivery ≥ 34 weeks
Model 1 1.26 0.99,1.59 1.30 1.02,1.67 1.37 1.07,1.74
Model 2 1.47 1.12,1.92 1.55 1.15,2.07 1.53 1.15,2.02
*adjusted through logistic regression for:
Model 1: maternal age and race/ethnicity
Model 2: maternal age, race/ethnicity, parity, pre-pregnancy BMI, years of
education
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Page 3 of 6undertaken. The perinatal mo r t a l i t yr a t ei no u rs t u d y ,
22/1000, was similar to the rates existing in Brazil at
that time [14], and much higher than that reported in
the HAPO study (5.6/1000). Improved obstetric care,
for example, fetal monitoring, and treatment of
metabolic instability in early life and complications of
macrosomia, can counterbalance some of the risk
resulting from gestational diabetes. Second, women
with a fasting glucose higher then 105 mg/dl at testing
or at any point during follow-up were excluded from
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Figure 1 Incidence of perinatal death according to glucose categories for fasting, 1-hour and 2-hour moments of the 75 gr oral
glucose tolerance test. Exact Cochrane-Armitage test for trend for overall perinatal mortality (fasting = 0.30; 1-hour = 0.05; 2-hour = 0.13) and
for later perinatal mortality (fasting = 0.06; 1-hour = 0.01; 2-hour <0.01). To convert mg/dl to mmol/L divide by 18.02.
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hyperglycemia than that of EBDG.
Ramtoola et al. [9] found slightly lower perinatal mor-
tality (22/1000) with gestational diabetes as defined by
the World Health Organization diagnostic criteria
(impaired glucose tolerance) than that of the back-
ground population of Mauritian women (26/1000).
However, the prevalence of gestational diabetes, ascer-
tained without universal screening, was only 1% in their
study (184 women, 98 characterized as having impaired
glucose tolerance and 86 as having diabetes, out of
approximately 4500 annual births in each of the 4 years
studied). This prevalence contrasts with that of 7.8%
with universal screening in our study [3]. The lower
mortality they found could thus be due to unexplained
confounding resulting from non-universal screening. In
previous analyses of our Brazilian cohort [3], we found a
small, though not statistically significant, increase in
perinatal mortality [RR = 1.66; 95% CI 0.91, 2,96] when
using the WHO criteria. As our previous study report-
ing mortality associations [3] analyzed additional out-
comes, its exclusions were somewhat different, resulting
in associations of a slightly different magnitude than
those reported here.
The main strength of our study is its prospective
cohort design. Moreover, given the controversial nature
of the association between lesser than diabetes hypergly-
cemia and perinatal death, our study was able to
demonstrates that, in settings of low detection and treat-
ment of gestational diabetes, positive associations of glu-
cose values with perinatal death are more evident in late
pregnancy, a period when deaths associated to prema-
turity complications are improbable [15]. Additionally,
we demonstrate that both current GDM diagnostic cri-
teria detect women having this increased risk.
Our study has some limitations. Instability is present
because of the small number of perinatal deaths. This
small number also hindered our ability to evaluate the
presence of a glucose threshold for increased perinatal
mortality. However, at glucose categories 5 (for fasting
90-94 mg/dl, for 1 h 172-193 mg/dl, and 2 h 140-157
mg/dl) the increase in risk is evident, regardless of the
period of pregnancy (Figure 1). Additionally, as we did
not retest women for GDM after week 28, it is also pos-
sible that the associations here described underestimate
the true associations, as deaths in women who only
developed GDM after week 28 will be considered as not
associated with GDM, thus diluting the association.
Finally, other, unmeasured risk factors for perinatal
death could confound the reported associations. In this
regard, the additional inclusion of preeclampsia in the
logistic model did not materially alter the association
found (data not shown).
Conclusions
Our study shows an association between glycemia and
perinatal mortality in late pregnancy in women not trea-
ted for gestational diabetes and receiving standard
obstetric care in the early 1990s in Brazil. Both the
WHO and the IADPSG criteria detected women having
this increased risk. Much of the world’s population lives
in settings with a level of perinatal mortality and quality
of obstetric care similar to or worse than that present in
our study. Additionally, women in these settings, predo-
minantly in low and middle-income countries, are suf-
fering the nutritional transition, which increases the risk
for hyperglycemia in pregnancy. Thus, gestational dia-
betes may continue to be an important cause of perina-
tal mortality for many of the world’sc h i l d b e a r i n g
women.
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Table 3 Association of perinatal mortality* with different
diagnostic criteria for gestational diabetes for women
delivering at different gestational periods
IADSPG WHO
OR 95% CI OR 95% CI
Total sample (n = 4398)
Model 1 1.38 0.86,2.22 1.46 0.74,2.85
Model 2 1.47 0.85,2.54 2.11 1.06,4.23
Delivery between 28 and 33 weeks (n =
168)
Model 1 0.75 0.28,1.99 0.82 0.16,4.19
Model 2 0.63 0.19,2.06 1.12 0.20,6.30
Delivery ≥ 34 weeks (n = 4230)
Model 1 1.78 1.01,3.17 1.98 0.92,4.25
Model 2 2.21 1.15,4.27 3.10 1.39,6.88
*adjusted through logistic regression for: maternal age and race/ethnicity
(Model 1) and maternal age, race/ethnicity, parity, pre-pregnancy BMI, years of
education (Model 2). IADSPG = International Association of Diabetes and
Pregnancy Study Groups (a fasting glucose ≥ 5.1 mmol/L (92 mg/dl); a one
hour result of ≥ 10.0 mmol/L (180 mg/dl); or a two hour result of ≥ 8.5 mmol/
L (153 mg/dl).
WHO = World Health Organization (a two hour post load glycemia > 7.8
mmol/L (140 mg/dl).
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